InVivo Therapeutics has appointed Richard Toselli chief medical officer of the Cambridge, MA, biotech. Toselli, a spinal neurosurgeon, previously served as chief medical officer for Australia-based Cochlear Limited. His experience also includes posts at Sanofi (NYSE: [[ticker:SNY]]), Covidien, DePuy, and Johnson & Johnson (NYSE: [[ticker:JNJ]]). InVivo is developing treatments for spinal cord injuries.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
